{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:58:00Z","timestamp":1791903480712,"version":"4.3.4"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30-ES013508"],"award-info":[{"award-number":["P30-ES013508"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA90744"],"award-info":[{"award-number":["R01-CA90744"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.mce.2018.07.002","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T20:53:51Z","timestamp":1537390431000},"page":"82-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"special_numbering":"C","title":["AKR1C3 (type 5 17\u03b2-hydroxysteroid dehydrogenase\/prostaglandin F synthase): Roles in malignancy and endocrine disorders"],"prefix":"10.1016","volume":"489","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3937-1066","authenticated-orcid":false,"given":"Trevor M.","family":"Penning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2018.07.002_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0960-0760(95)00039-3","article-title":"The molecular biology of androgenic 17b-hydroxysteroid dehydrogenases","volume":"53","author":"Andersson","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2018.07.002_bib4","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1200\/JCO.2007.15.9749","article-title":"Phase 1 clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven","volume":"28","author":"Attard","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mce.2018.07.002_bib5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tem.2004.09.004","article-title":"The backdoor pathway to dihydrotestosterone","volume":"15","author":"Auchus","year":"2004","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.mce.2018.07.002_bib6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI200318012","article-title":"Biosynthesis of 5-deoxy-delta-12,14-PGJ2 and the ligation of PPARgamma","volume":"112","author":"Bell-Parikh","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2018.07.002_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cbi.2012.10.028","article-title":"Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line","volume":"202","author":"Berani\u010d","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mce.2018.07.002_bib20","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","article-title":"Abiraterone and increased survival in metastatic prostate cancer","volume":"364","author":"de Bono","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2018.07.002_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cbi.2008.10.058","article-title":"The human short-chain dehydrogenase\/reductase (SDR) superfamily: a bioinformatics summary","volume":"178","author":"Bray","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mce.2018.07.002_bib9","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1021\/bi972725u","article-title":"Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo[a]pyrene-7,8-dione","volume":"37","author":"Burczynski","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2018.07.002_bib10","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.4161\/cc.6.13.4453","article-title":"MAPK kinases as nucleo-cytoplasmic shuttles for PPARgamma","volume":"6","author":"Burgermeister","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.mce.2018.07.002_bib11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bcp.2007.09.008","volume":"75","author":"Byrns","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mce.2018.07.002_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jsbmb.2009.12.009","article-title":"Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its overexpression in breast cancer","volume":"118","author":"Byrns","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2018.07.002_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsbmb.2010.11.004","article-title":"Inhibitors of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights","volume":"125","author":"Byrns","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2018.07.002_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jsbmb.2011.12.012","article-title":"Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5\u03b1-reductase inhibitor finasteride","volume":"130","author":"Byrns","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2018.07.002_bib15","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1073\/pnas.1107898108","article-title":"Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer","volume":"108","author":"Chang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2018.07.002_bib16","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1016\/j.bmcl.2012.03.085","article-title":"Crystal structures of AKR1C3 containing an N-(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer","volume":"22","author":"Chen","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.mce.2018.07.002_bib17","doi-asserted-by":"crossref","first-page":"33484","DOI":"10.1074\/jbc.M703414200","article-title":"Elucidation of a complete kinetic mechanism for a mammalian hydroxysteroid dehydrogenase (HSD) and identification of all enzyme forms on the reaction coordinate: the example of rat liver 3alpha-HSD (AKR1C9)","volume":"282","author":"Cooper","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"Pt 3","key":"10.1016\/j.mce.2018.07.002_bib18","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1042\/bj20021818","article-title":"Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism","volume":"373","author":"Crosas","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.mce.2018.07.002_bib19","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1200\/JCO.2009.25.9259","article-title":"Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer","volume":"28","author":"Danila","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mce.2018.07.002_bib21","first-page":"505","article-title":"The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs","volume":"63","author":"Desmond","year":"2003","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2018.07.002_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsbmb.2015.09.037","article-title":"Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells","volume":"155","author":"Doig","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2018.07.002_bib23","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M115.662155","article-title":"The steroidogenic enzyme AKR1C3 regulates stability of the ubiquitin ligase Siah2 in prostate cancer cells","volume":"290","author":"Fan","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2018.07.002_bib24","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1158\/1078-0432.CCR-13-3483","article-title":"Canoncial androstenedione reduction is the predominat source of signaling androgens in hormone-refractory prostate cancer","volume":"20","author":"Fankhauser","year":"2014","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.mce.2018.07.002_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/erc.1.01048","article-title":"Increased expression of type 2 3a-hydroxysteroid dehydrogenase\/type 5 17b-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with the androgen receptor in prostate carcinoma","volume":"13","author":"Fung","year":"2006","journal-title":"Endocr. Relat. Canc."},{"key":"10.1016\/j.mce.2018.07.002_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1042\/BJ20051988","article-title":"Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases\/reductases and aldo-keto reductases with retinoids","volume":"399","author":"Gallego","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.mce.2018.07.002_bib27","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1073\/pnas.90.4.1440","article-title":"Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor","volume":"90","author":"Gearing","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.mce.2018.07.002_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134506","article-title":"Substrate specificity, inhibitor selectivity and structure-function relationships of aldo-keto reductase 1B15: a novel human retinaldehyde reductase","volume":"10","author":"Gim\u00e9nez-Dejoz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2018.07.002_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.freeradbiomed.2015.06.013","article-title":"Epigenetic regulation of Keap1-Nrf2 signaling","volume":"88","author":"Guo","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mce.2018.07.002_bib30","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2119\/molmed.2012.00296","article-title":"Aldo-keto reductase family 1 member C3 (AKR1C3) is a biomarker and therapeutic target for castration-resistant prostate cancer","volume":"18","author":"Hamid","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.mce.2018.07.002_bib31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cbi.2014.11.015","article-title":"The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism","volume":"234","author":"Hevir-Kene","year":"2015","journal-title":"Chem-Biol. Inter."},{"key":"10.1016\/j.mce.2018.07.002_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0092-8674(92)90479-V","article-title":"9-cis retinoic acid is a high affinity ligand for the retinoid X receptor","volume":"68","author":"Heyman","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.mce.2018.07.002_bib33","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1158\/0008-5472.CAN-09-2092","article-title":"Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer","volume":"70","author":"Hofland","year":"2010","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2018.07.002_bib34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biopha.2010.10.004","article-title":"Drug resistant MCF-7 cells exhibit epithelial-mesencyhmal transition gene expression pattern","volume":"65","author":"Iseri","year":"2011","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mce.2018.07.002_bib35","doi-asserted-by":"crossref","first-page":"11471","DOI":"10.1158\/0008-5472.CAN-06-1448","article-title":"17-Hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer","volume":"66","author":"Jansson","year":"2006","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2018.07.002_bib36","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/bj3260625","article-title":"Comparative anatomy of the aldo-keto reductase superfamily","volume":"326","author":"Jez","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.mce.2018.07.002_bib37","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/bbrc.1999.0704","article-title":"Human estrogenic 17beta-hydroxysteroid dehydrogenase: predominance of estrone reduction and its induction by NADPH","volume":"259","author":"Jin","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2018.07.002_bib38","doi-asserted-by":"crossref","first-page":"13054","DOI":"10.1021\/bi060591r","article-title":"Multiple steps determine the overall rate of the reduction of 5alpha-dihydrotestosterone catalyzed by human type 3 3alpha-hydroxysteroid dehydrogenase: implications for the elimination of androgens","volume":"45","author":"Jin","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2018.07.002_bib39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev.pharmtox.47.120505.105337","article-title":"Aldo-keto reductases and bioactivation\/detoxication","volume":"47","author":"Jin","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.mce.2018.07.002_bib40","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/onc.2017.371","article-title":"DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor","volume":"5","author":"Jing","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2018.07.002_bib41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1530\/EJE-14-0615","article-title":"Association analysis between the polymorphisms of HSD17B5 and HSD17B6 and risk of polycystic ovary syndrome in Chinese population","volume":"172","author":"Ju","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2018.07.002_bib42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1210\/me.2012-1313","article-title":"Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells","volume":"27","author":"Kaikkonen","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2018.07.002_bib43","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1128\/MCB.24.17.7559-7566.2004","article-title":"Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress","volume":"24","author":"Kajita","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mce.2018.07.002_bib44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12894-016-0164-4","article-title":"Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?","volume":"16","author":"Karunasinghe","year":"2016","journal-title":"BMC Urol."},{"key":"10.1016\/j.mce.2018.07.002_bib45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000445684","article-title":"A single nucleotide variant in the promoter region of 17beta-HSD type 5 gene influences external genitalia virilization in females with 21-hydroxylase deficiency","volume":"85","author":"Kaupert","year":"2016","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.mce.2018.07.002_bib46","doi-asserted-by":"crossref","first-page":"e8147","DOI":"10.1371\/journal.pone.0008147","article-title":"Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia","volume":"4","author":"Khanim","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2018.07.002_bib47","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/bjc.2014.83","article-title":"Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate","volume":"110","author":"Khanim","year":"2014","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.mce.2018.07.002_bib48","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s10637-014-0130-5","article-title":"In vitro and in vivo characterization of ASP9521: a novel selective, orally bioavailable inhibitor of 17b-hydroxysteroid dehydrogenase type 5 (17b-HSD5; AKR1C3)","volume":"32","author":"Kikuchi","year":"2014","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.mce.2018.07.002_bib49","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1158\/0008-5472.CAN-06-3043","article-title":"15-Deoxy-delta-12,14-prostgalandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain","volume":"67","author":"Kim","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2018.07.002_bib50","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1158\/0008-5472.CAN-13-2591","article-title":"Slug promotes survival during metastasis through suppression of Puma-mediated apoptosis","volume":"74","author":"Kim","year":"2014","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2018.07.002_bib51","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation","volume":"83","author":"Kliewer","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.mce.2018.07.002_bib52","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.ajpath.2014.04.010","article-title":"Castration induces up-regulation of intratumoral androgen biosynthesis and androgen receptor expression in an orthotopic VCaP human prostate cancer xenograft model","volume":"184","author":"Knuuttila","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2018.07.002_bib53","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1021\/bi051861t","article-title":"Prostaglandin F2\u03b1 formation from prostaglandin H2 by prostaglandin F synthase (PGFS): crystal structure of PGFS containing bimatoprost","volume":"45","author":"Komoto","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2018.07.002_bib54","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1101\/gr.091991.109","article-title":"Positional conservation and amino-acids shape the correct diagnosis and population frequencies of benign and damaging personal amino-acid mutations","volume":"15","author":"Kumar","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.mce.2018.07.002_bib55","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/molehr\/gau023","article-title":"Generation of human endometrial knockout cell lines with the CRISPR\/Cas9 system confirms the prostaglandin F2\u03b1 synthase activity of aldo-ketoreductase 1B1","volume":"20","author":"Lacroix P\u00e9pin","year":"2014","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.mce.2018.07.002_bib56","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/355359a0","article-title":"9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha","volume":"355","author":"Levin","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.mce.2018.07.002_bib57","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3892\/ijmm.2013.1268","article-title":"15-Deoxy-\u0394(12,14)-prostaglandin J(2) induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer cell lines","volume":"31","author":"Li","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.mce.2018.07.002_bib58","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1021\/jm3017656","article-title":"Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17beta-hydroxysteroid dehydrogenase\/prostaglandin F synthase) in castrate-resistant prostate cancer","volume":"56","author":"Liedtke","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mce.2018.07.002_bib59","first-page":"1971","article-title":"Expression and characterization of recombinant type 2 3a-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3a\/17b-HSD activity and cellular distribution","volume":"11","author":"Lin","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2018.07.002_bib60","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.steroids.2004.09.014","article-title":"Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3a-hydroxysteroid dehydrogenase\/type 5 17b-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate","volume":"69","author":"Lin","year":"2004","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2018.07.002_bib61","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1158\/0008-5472.CAN-14-3080","article-title":"Intracrine androgens and AKR1C3 activation confer resistance to Enzalutamide in prostate cancer","volume":"75","author":"Liu","year":"2015","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2018.07.002_bib62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/1535-7163.MCT-16-0186","article-title":"Inhibition of AKR1C3 activation overcomes resistance to abiraterone in advanced prostate cancer","volume":"16","author":"Liu","year":"2017","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.mce.2018.07.002_bib63","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s10637-014-0101-x","article-title":"Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I\/II study","volume":"32","author":"Loriot","year":"2014","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.mce.2018.07.002_bib64","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jsbmb.2010.12.013","article-title":"17\u03b2-Hydroxysteroid dehydrogenases (17\u03b2-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development","volume":"125","author":"Marchais-Oberwinkler","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2018.07.002_bib65","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/oxfordjournals.jbchem.a022211","article-title":"Identification of a principal mRNA species for human 3a-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity","volume":"124","author":"Matsuura","year":"1998","journal-title":"J. Biochem."},{"key":"10.1016\/j.mce.2018.07.002_bib66","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1158\/0008-5472.CAN-12-1335","article-title":"Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors","volume":"72","author":"Mitsiades","year":"2012","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2018.07.002_bib67","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2008-2374","article-title":"Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis","volume":"94","author":"Nakamura","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2018.07.002_bib1","doi-asserted-by":"crossref","first-page":"S0140","DOI":"10.1016\/S0140-6736(15)60331-2","article-title":"Effect of insulin on AKR1C3 expression in female adipose tissue: in vivo and in vitro study of adipose androgen generation in polycystic ovary syndrome","volume":"385","author":"O'Reilly","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2018.07.002_bib2","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.2017-00947","article-title":"AKR1C3-Mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome","volume":"102","author":"O'Reilly","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2018.07.002_bib68","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/13543776.2017.1379503","article-title":"Aldo-keto reductase (akr) 1C3 inhibitors: a patent review","volume":"27","author":"Penning","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.mce.2018.07.002_bib69","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/bj3510067","article-title":"Human 3a-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones","volume":"351","author":"Penning","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.mce.2018.07.002_bib70","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsbmb.2014.12.003","article-title":"Promiscuity and diversity in 3-ketosteroid reductases","volume":"151","author":"Penning","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2018.07.002_bib71","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/FPC.0000000000000226","article-title":"Impact of nonsynonymous single nucleotide polymorphisms on in-vitro metabolism of exemestane by hepatic cytosolic reductases","volume":"26","author":"Platt","year":"2016","journal-title":"Pharmacogenetics Genom."},{"key":"10.1016\/j.mce.2018.07.002_bib72","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1078-0432.CCR-14-2352","article-title":"ERG\/AKR1C3\/AR constitutes a feed-forward loop for AR signaling in prostate cancer cells","volume":"21","author":"Powell","year":"2015","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.mce.2018.07.002_bib73","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1210\/me.2004-0032","article-title":"Crystal structures of the multispecific 17beta-hydroxysteroid dehydrogenase type 5: critical androgen regulation in human peripheral tissues","author":"Qiu","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2018.07.002_bib74","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1074\/jbc.273.4.1855","article-title":"Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma","volume":"273","author":"Reginato","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2018.07.002_bib75","first-page":"17","article-title":"Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1)","volume":"1447","author":"Rheault","year":"1999","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.mce.2018.07.002_bib76","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2119\/molmed.2012.00296","article-title":"Aldo-keto reductase 1 member C3 (AKR1C3) is a biomarker and therapeutic target for castration-resistant prostate cancer","volume":"18","author":"Rizal","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.mce.2018.07.002_bib77","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1210\/en.2002-0032","article-title":"Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells","volume":"144","author":"Rizner","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2018.07.002_bib78","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1210\/jc.2003-031434","article-title":"Expression, localization and signaling of prostaglandin F2a receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways","volume":"89","author":"Sales","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2018.07.002_bib79","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(10)60172-9","article-title":"Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study","volume":"375","author":"Scher","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2018.07.002_bib80","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1021\/bi9723055","article-title":"Mutagenesis of 3 alpha-hydroxysteroid dehydrogenase reveals a \"push-pull\" mechanism for proton transfer in aldo-keto reductases","volume":"37","author":"Schlegel","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2018.07.002_bib81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mce.2005.10.024","article-title":"Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid tissues","volume":"248","author":"Sharma","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2018.07.002_bib82","doi-asserted-by":"crossref","first-page":"14145","DOI":"10.1074\/jbc.M500901200","article-title":"alpha,beta-Unsaturated ketone is the core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma","volume":"280","author":"Shiraki","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2018.07.002_bib83","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cbi.2012.11.012","article-title":"Altered expression of genes involved in progesterone biosynthesis, metabolism and action in endometrial cancer","volume":"202","author":"Sinreih","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mce.2018.07.002_bib84","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cbi.2014.11.009","article-title":"Expression of AKR1B1, AKR1C3 and other genes of prostaglandin F2\u03b1 biosynthesis and action in ovarian endometriosis tissue and in model cell lines","volume":"234","author":"Sinreih","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mce.2018.07.002_bib85","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ejhg.2014.129","article-title":"Fine mapping analysis confirms and strengthens linkage of four chromosomal regions in familial hypospadias","volume":"23","author":"Soderhall","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.mce.2018.07.002_bib86","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1158\/0008-5472.CAN-05-4000","article-title":"Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer","volume":"66","author":"Stanbrough","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2018.07.002_bib87","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0303-7207(00)00432-9","article-title":"Expression of the 17beta-hydroxysteroid dehydrogenase type 5 mRNA in the human brain","volume":"171","author":"Steckelbroeck","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2018.07.002_bib88","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00795-007-0365-8","article-title":"In situ production of sex steroids in human breast carcinoma","volume":"40","author":"Suzuki","year":"2007","journal-title":"Med. Mol. Morphol."},{"key":"10.1016\/j.mce.2018.07.002_bib89","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0014-5793(99)01551-3","article-title":"cDNA cloning, expression and characterization of human prostaglandin F synthase","volume":"462","author":"Suzuki-Yamamoto","year":"1999","journal-title":"FEBS Lett."},{"issue":"Pt B","key":"10.1016\/j.mce.2018.07.002_bib90","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2015.06.021","article-title":"Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease","volume":"88","author":"Tebay","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mce.2018.07.002_bib91","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1746-1596-9-42","article-title":"AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression","volume":"9","author":"Tian","year":"2014","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.mce.2018.07.002_bib92","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00239-010-9338-y","article-title":"Functional significance may underlie the taxonomic utility of single amino-acid substitutions in conserved proteins","volume":"70","author":"Tyler","year":"2010","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.mce.2018.07.002_bib93","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1476-4598-8-121","article-title":"Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers","volume":"8","author":"Veli\u00e7a","year":"2009","journal-title":"Mol. Canc."},{"key":"10.1016\/j.mce.2018.07.002_bib94","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1021\/bi036046x","article-title":"Crystal structure of human prostaglandin F synthase (AKR1C3)","volume":"43","author":"Yamada","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2018.07.002_bib95","article-title":"Genome-wide analysis of human disease alleles reveals that their locations are correlated in paralogous proteins","volume":"41","author":"Yandell","year":"2008","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.mce.2018.07.002_bib96","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1158\/1078-0432.CCR-13-1151","article-title":"Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth","volume":"19","author":"Yepuru","year":"2013","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.mce.2018.07.002_bib97","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.mce.2015.07.008","article-title":"11beta-Prostaglandin F2alpha, a bioactive metabolite catalyzed by AKR1C3, stimulates prostaglandin F receptor and induces slug expression in breast cancer","volume":"413","author":"Yoda","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2018.07.002_bib98","article-title":"Molecular markers in sex hormone pathway genes associated with the efficacy of androgen-deprivation therapy for prostate cancer","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720718302168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720718302168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:08:30Z","timestamp":1759586910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720718302168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":98,"alternative-id":["S0303720718302168"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2018.07.002","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AKR1C3 (type 5 17\u03b2-hydroxysteroid dehydrogenase\/prostaglandin F synthase): Roles in malignancy and endocrine disorders","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2018.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}